Legis Daily

Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019

USA116th CongressHR-3396| House 
| Updated: 6/21/2019
F. James Sensenbrenner

F. James Sensenbrenner

Republican Representative

Wisconsin

Cosponsors (23)
Paul A. Gosar (Republican)David Loebsack (Democratic)Tom O'Halleran (Democratic)Mark Pocan (Democratic)Lisa Blunt Rochester (Democratic)Jefferson Van Drew (Republican)Max Rose (Democratic)Bobby L. Rush (Democratic)Thomas R. Suozzi (Democratic)Thomas Massie (Republican)G. K. Butterfield (Democratic)David E. Price (Democratic)Filemon Vela (Democratic)Eleanor Holmes Norton (Democratic)Joe Neguse (Democratic)James P. McGovern (Democratic)Ron Kind (Democratic)Julia Brownley (Democratic)Brian K. Fitzpatrick (Republican)Ed Perlmutter (Democratic)Gwen Moore (Democratic)Susie Lee (Democratic)Katie Porter (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019 This bill allows the National Institutes of Health to expand, intensify, and coordinate its activities with respect to functional gastrointestinal and motility disorders (FGIMDs), including by expanding basic and clinical research into FGIMDs by implementing the research recommendations of the National Commission on Digestive Diseases, providing support for the establishment of centers of excellence on FGIMDs, supporting innovative approaches to educating health care providers and patients regarding strategies that improve patient-provider relationships and care, directing the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to provide the necessary funding for the continued expansion and advancement of the FGIMDs research portfolio, and directing NIDDK and the Eunice Kennedy Shriver National Institute of Child Health and Human Development to expand research into FGIMDs that impact children. The Department of Health and Human Services may engage in public awareness and education activities to increase understanding and recognition of FGIMDs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 20, 2019
Introduced in House
Jun 20, 2019
Referred to the House Committee on Energy and Commerce.
Jun 21, 2019
Referred to the Subcommittee on Health.
  • June 20, 2019
    Introduced in House


  • June 20, 2019
    Referred to the House Committee on Energy and Commerce.


  • June 21, 2019
    Referred to the Subcommittee on Health.

Health

Digestive and metabolic diseasesGovernment information and archivesHealth information and medical recordsHealth programs administration and fundingMedical researchMedical tests and diagnostic methodsResearch administration and funding

Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019

USA116th CongressHR-3396| House 
| Updated: 6/21/2019
Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019 This bill allows the National Institutes of Health to expand, intensify, and coordinate its activities with respect to functional gastrointestinal and motility disorders (FGIMDs), including by expanding basic and clinical research into FGIMDs by implementing the research recommendations of the National Commission on Digestive Diseases, providing support for the establishment of centers of excellence on FGIMDs, supporting innovative approaches to educating health care providers and patients regarding strategies that improve patient-provider relationships and care, directing the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to provide the necessary funding for the continued expansion and advancement of the FGIMDs research portfolio, and directing NIDDK and the Eunice Kennedy Shriver National Institute of Child Health and Human Development to expand research into FGIMDs that impact children. The Department of Health and Human Services may engage in public awareness and education activities to increase understanding and recognition of FGIMDs.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 20, 2019
Introduced in House
Jun 20, 2019
Referred to the House Committee on Energy and Commerce.
Jun 21, 2019
Referred to the Subcommittee on Health.
  • June 20, 2019
    Introduced in House


  • June 20, 2019
    Referred to the House Committee on Energy and Commerce.


  • June 21, 2019
    Referred to the Subcommittee on Health.
F. James Sensenbrenner

F. James Sensenbrenner

Republican Representative

Wisconsin

Cosponsors (23)
Paul A. Gosar (Republican)David Loebsack (Democratic)Tom O'Halleran (Democratic)Mark Pocan (Democratic)Lisa Blunt Rochester (Democratic)Jefferson Van Drew (Republican)Max Rose (Democratic)Bobby L. Rush (Democratic)Thomas R. Suozzi (Democratic)Thomas Massie (Republican)G. K. Butterfield (Democratic)David E. Price (Democratic)Filemon Vela (Democratic)Eleanor Holmes Norton (Democratic)Joe Neguse (Democratic)James P. McGovern (Democratic)Ron Kind (Democratic)Julia Brownley (Democratic)Brian K. Fitzpatrick (Republican)Ed Perlmutter (Democratic)Gwen Moore (Democratic)Susie Lee (Democratic)Katie Porter (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Digestive and metabolic diseasesGovernment information and archivesHealth information and medical recordsHealth programs administration and fundingMedical researchMedical tests and diagnostic methodsResearch administration and funding